BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 1-Year High at $2.20

Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQGet Free Report) hit a new 52-week high on Thursday . The stock traded as high as $2.20 and last traded at $2.09, with a volume of 275911 shares trading hands. The stock had previously closed at $2.03.

BioRestorative Therapies Trading Up 3.0 %

The stock has a market cap of $3.43 billion, a price-to-earnings ratio of -1.95 and a beta of 102.36. The stock’s 50-day moving average price is $1.37 and its 200-day moving average price is $1.51.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Recommended Stories

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.